There has been a great deal of debate on the
efficacy of certain compounds in the treatment
of CAPD derived peritonitis. For example Korzets
Z and Lang R (2001), and Kent JR and Almond MK.
(2000) believe that the efficacy of Vancomysin
is very important in treating CAPD led peritonitis.
Vancomycin was found to be effective against a
wide range of bacterial strains and the effect
of the treatment was long lasting, which prevented
repeated hospitalization expenses. However, many
other experts such as Gucek A, Bren AF, Lindic
J et. al. (1994) and Alves FR, Dantas RC (1997)
have argued that other alternatives to Vancomycin,
particularly Cefazolin, seem to show significant
if not better cure rates. They also argue that
Vancomysin resistant bacteria like Vancomycin
Resistant Enterococci have been increasingly posing
problems to doctors. Cefazolin in particular,
is ineffective against methicillin resistant organisms,
which constitute 15-43% of the CAPD infections.
Over the years, third generation Cephalosporins
have been accused of increasing infections in
the human body and many experts believe that this
may due to the indiscriminate use of these drugs.
Enterococcal infections for example, have been
increasingly resistant to Cephalosporins. In fact
Barlett JG, Bradley SF, Herwaldt LA, et al (1999)
and Teitelbaum (2001) believe that the increasing
incidence of infections is proportional to the
increasing use of cephalosporins for treating
peritonitis.
Many doctors also believe that an empirical prescription
of antibiotics can work significantly against
CAPD infections because it will act on a wide
range of bacterial strains. This will also help
in a way to provide a clue on the possible bacterial
strain that has infected the patient. If the bacterial
infection cannot be controlled with the initial
broad spectrum antibiotic, specific antibiotics
may be used to deal with the possible strain that
is causing the problem. Doctors advise that the
use of specific antibiotics at the first stage
itself is not a good form of approaching the infection
given the fact that many antibiotics have different
kinds of adverse effects on the patients. In addition,
the issue of drug resistance is a very important
factor that needs to be considered before administering
any of the specific antibiotics [McDonald, 2002;
Sandoe JA, Gokal R, Struthers JK (1997)]. The
use of Vancomycin has long been discouraged by
medical scientists because of Vancomycin Resistant
Enterococci, which escapes the drug. Newer approaches
to treating CAPD peritonitis involve the use of
combination medicines that have been giving good
results. For example Chadwick DH, Agarwal S, Vora
BJ, Hair M, McKewan A, and Gokal R (1999) have
proved through their experiments that a combination
of Vancomycin combined with Netilmicin has a cure
rate of more than eighty percent. This is a very
positive finding which will contribute significantly
towards the treatment of peritonitis. This study
also must be followed up with the study of bacterial
resistance patterns to evolve better treatment
regimens that can effectively kill a large number
of bacterial strains.
It would be important to note that CAPD related
infections were not a serious cause of diseases
a few years before, as noted by Ng R, Zabetakis
PM, Callahan C, Krapf R, Sasak C, Fritzsch S,
Pollock A, Balter P, and Michelis MF (1999). However,
Sanyal D, Williams AJ, Johnson AP, George RC (1993)
notes that peritonitis can be caused in patients
because of long term treatment with Intra-peritoneal
Vancomycin, which is part of the CAPD procedure.
Sanyal et al (1993) warns medical practitioners
from administering glycopeptides repeatedly to
these patients since that can encourage bacterial
resistance. Putting these two observations together
it may be seen that there is a chance for the
patient to develop peritonitis in the long run
from hospital procedures that are part of CAPD
procedures. This means that care must be taken
by the patients as well as the health workers
to be always on the lookout for procedures that
may become controversial in the long run.
The alertness of the patients and doctors assumes
significance considering the fact that new resistant
forms of bacteria have been isolated recently
in CAPD patients [Klein G, Zill E, Schindler R,
Louwers J, 1998; Neef PA, Polenakovik H, Clarridge
JE, Saklayen M, Bogard L, Bernstein JM, 2003]
Hence, medical practices must be carefully planned
to reduce chances of bacterial resistance as far
as possible.
While the debates on the use of medicines go
on, doctors have come up with interesting observations
of bad diagnosis. Often conditions that are considered
to be cases of peritonitis is not so, and may
be simply a case of the reaction of the body’s
defense mechanisms. Experts like Chan MK, Chow
L, Lam SS, and Jones B (1988) have observed that
a condition called peritoneal eosinophilia in
patients can be caused by non-bacterial agents
like allergies, reaction of the body to surgical
components, gas formation in the area of the insertion
etc. In such cases, administering antibiotics
will not lead to a cure [Nankivell BJ, Pacey D,
Gordon DL 1991; Sridhar R, Thornley-Brown D, Kant
KS, 1990; Dobbie JW, 1993]. Hence, in all cases
of CAPD peritonitis infections, it will be wise
to ascertain the reason for the disease rather
than administering the medicines in haste. Der-Cherng
Tarng, Tzen Wen Chen and Chin-Huang Chen (2001)
notes that peritonitis in CAPD patients does not
always warrant the use of antibiotics. What is
needed is a clear diagnosis and confirmation of
bacterial infection.